Paul W Manley (Paul Manley)

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 3

Top Topics

Chronic Myeloid Leukemia

Tyrosine Kinase

Top Venues

Angewandte Chemie (International ed. in English)

This page only lists publications with an associated author ORCID identifier.

Publications

Paul W Manley
Evidence supporting that the attribution of first success in use of arsenic for the treatment of leukaemia should be to David Lissauer (1836-1892). Leukemia 36 (6) (2022)
Wolfgang Jahnke, Johannes Paladini, Judith Maria Habazettl, Andrea Wiget, Alice Loo, Sandra W Cowan Jacob, Stephan Grzesiek, Paul W Manley
Correspondence on "Synergy and Antagonism between Allosteric and Active-Site Inhibitors of Abl Tyrosine Kinase". Angewandte Chemie (International ed. in English) 61 (46) (2022)
Patrick Schöffski, Yemarshet Gebreyohannes, Thomas Van Looy, Paul W Manley, Joseph D Growney, Matthew Squires, Agnieszka Wozniak
In Vivo Evaluation of Fibroblast Growth Factor Receptor Inhibition in Mouse Xenograft Models of Gastrointestinal Stromal Tumor. Biomedicines 10 (5) (2022)